16.43
price down icon0.18%   -0.03
pre-market  Vorhandelsmarkt:  16.55   0.12   +0.73%
loading

Amylyx Pharmaceuticals Inc Aktie (AMLX) Neueste Nachrichten

pulisher
May 05, 2026

Amylyx Investors To Get $6.5M In ALS Drug Settlement - Law360

May 05, 2026
pulisher
May 05, 2026

Amylyx Pharmaceuticals Announces U.S. Expanded Access Program for Adults with Post-Bariatric Hypoglycemia - Business Wire

May 05, 2026
pulisher
May 05, 2026

Sarepta, Amylyx and Neumora look ahead to key catalysts as Q1 earnings roll in - BioSpace

May 05, 2026
pulisher
May 03, 2026

MSN Money - MSN

May 03, 2026
pulisher
May 03, 2026

H.C. Wainwright raises Amylyx stock price target to $34 on trial confidence - Investing.com

May 03, 2026
pulisher
May 01, 2026

AMLX Stock Price, Quote & Chart | AMYLYX PHARMACEUTICALS INC (NASDAQ:AMLX) - ChartMill

May 01, 2026
pulisher
Apr 30, 2026

Amylyx Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026 - BioSpace

Apr 30, 2026
pulisher
Apr 30, 2026

Amylyx’s ORION Trial in Progressive Supranuclear Palsy Reaches Completion: What Investors Should Watch - TipRanks

Apr 30, 2026
pulisher
Apr 30, 2026

Press Release: Amylyx Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026 - Moomoo

Apr 30, 2026
pulisher
Apr 30, 2026

Amylyx sets May 7 earnings report, 8 a.m. ET webcast - Stock Titan

Apr 30, 2026
pulisher
Apr 30, 2026

Amylyx Pharmaceuticals (AMLX) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Apr 30, 2026
pulisher
Apr 30, 2026

Bank of America Securities Reaffirms Their Buy Rating on Amylyx Pharmaceuticals Inc (AMLX) - The Globe and Mail

Apr 30, 2026
pulisher
Apr 29, 2026

Mizuho Adjusts Price Target on Amylyx Pharmaceuticals to $21 From $19, Maintains Outperform Rating - marketscreener.com

Apr 29, 2026
pulisher
Apr 28, 2026

BofA raises Amylyx Pharmaceuticals stock price target on model updates By Investing.com - Investing.com Nigeria

Apr 28, 2026
pulisher
Apr 28, 2026

BofA raises Amylyx Pharmaceuticals stock price target on model updates - Investing.com

Apr 28, 2026
pulisher
Apr 28, 2026

Mizuho raises Amylyx stock price target on lower expense outlook By Investing.com - Investing.com India

Apr 28, 2026
pulisher
Apr 28, 2026

Mizuho Forecasts Strong Price Appreciation for Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock - MarketBeat

Apr 28, 2026
pulisher
Apr 28, 2026

symbol__ Stock Quote Price and Forecast - CNN

Apr 28, 2026
pulisher
Apr 28, 2026

Mizuho raises Amylyx stock price target on lower expense outlook - Investing.com

Apr 28, 2026
pulisher
Apr 27, 2026

Amylyx Pharmaceuticals Q3 2025 Earnings Preview - MSN

Apr 27, 2026
pulisher
Apr 24, 2026

Amylyx Pharmaceuticals, Inc. ($AMLX) Co-CEO and Director 2025 Pay Revealed - Quiver Quantitative

Apr 24, 2026
pulisher
Apr 23, 2026

[ARS] Amylyx Pharmaceuticals, Inc. SEC Filing - Stock Titan

Apr 23, 2026
pulisher
Apr 23, 2026

Executive pay, avexitide milestones and 2026 vote at Amylyx (NASDAQ: AMLX) - Stock Titan

Apr 23, 2026
pulisher
Apr 22, 2026

AMLX (Amylyx Pharmaceuticals Inc.) reports narrower Q4 2025 loss than estimates, shares climb 3.55 percent on positive investor sentiment.Revenue Per Share - Cổng thông tin điện tử tỉnh Lào Cai

Apr 22, 2026
pulisher
Apr 22, 2026

AMLX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Apr 22, 2026
pulisher
Apr 21, 2026

Amylyx (AMLX) Stock Stop Limit Order (-3.24%) 2026-04-20Pro Level Trade Signals - Xã Thanh Hà

Apr 21, 2026
pulisher
Apr 20, 2026

Stock Traders Purchase High Volume of Call Options on Amylyx Pharmaceuticals (NASDAQ:AMLX) - MarketBeat

Apr 20, 2026
pulisher
Apr 17, 2026

Amylyx Pharmaceuticals stock hits 52-week high at 17.5 USD By Investing.com - Investing.com Australia

Apr 17, 2026
pulisher
Apr 17, 2026

Analysts Offer Insights on Healthcare Companies: Ceribell, Inc. (CBLL), ANI Pharmaceuticals (ANIP) and Amylyx Pharmaceuticals Inc (AMLX) - The Globe and Mail

Apr 17, 2026
pulisher
Apr 16, 2026

Amylyx Pharmaceuticals (NASDAQ:AMLX) Reaches New 12-Month HighShould You Buy? - MarketBeat

Apr 16, 2026
pulisher
Apr 16, 2026

Amylyx Pharmaceuticals stock hits 52-week high at 17.5 USD - Investing.com

Apr 16, 2026
pulisher
Apr 16, 2026

Guggenheim Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Maintains Target Price $30 - Moomoo

Apr 16, 2026
pulisher
Apr 15, 2026

Amylyx Pharmaceuticals Sets Up Q3 Phase 3 Avexitide Data Readout, Eyes Potential 2027 Launch - Yahoo Finance

Apr 15, 2026
pulisher
Apr 13, 2026

Bull Run: What is Amylyx Pharmaceuticals Incs book value per share2026 Dividend Review & Daily Profit Maximizing Tips - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 10, 2026

Amylyx Pharmaceuticals, Inc. (AMLX) stock price, news, quote and history - Yahoo Finance Singapore

Apr 10, 2026
pulisher
Apr 10, 2026

Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - Finviz

Apr 10, 2026
pulisher
Apr 10, 2026

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Apr 10, 2026
pulisher
Apr 10, 2026

Layoff Watch: Is Amylyx Pharmaceuticals Inc stock a smart retirement pick2026 Patterns & AI Powered Trade Plan Recommendations - baoquankhu1.vn

Apr 10, 2026
pulisher
Apr 09, 2026

AMLX SEC FilingsAmylyx Pharmaceuticals 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 09, 2026
pulisher
Apr 08, 2026

Amylyx Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference - BioSpace

Apr 08, 2026
pulisher
Apr 08, 2026

Buy Rating on Amylyx: De-Risked Avexitide Phase III Study and Significant PBH Market Opportunity Support 2027 Launch Potential - TipRanks

Apr 08, 2026
pulisher
Apr 08, 2026

A Look At Amylyx Pharmaceuticals (AMLX) Valuation As Avexitide Hits A Key Phase 3 LUCIDITY Milestone - Sahm

Apr 08, 2026
pulisher
Apr 06, 2026

Amylyx Pharmaceuticals Inc (AMLX) Shares Up 6.66% on Apr 6 - GuruFocus

Apr 06, 2026
pulisher
Apr 06, 2026

Amylyx Pharmaceuticals Shares Rise 6.9% on Positive News - National Today

Apr 06, 2026
RDY RDY
$13.26
price down icon 0.67%
$22.99
price up icon 2.13%
RGC RGC
$27.27
price down icon 0.33%
$135.06
price up icon 0.74%
$15.52
price up icon 2.11%
$572.20
price down icon 1.55%
Kapitalisierung:     |  Volumen (24h):